Liver Injury Following Tinospora Cordifolia Consumption: Drug-Induced AIH, or AIH?

Overview

Journal J Clin Exp Hepatol

Publisher Elsevier

Specialty Gastroenterology

Date 2022 Jan 24

PMID 35068778

Authors

Einar S Bjornsson

Victor J Navarro

Naga Chalasani

Affiliations

Soon will be listed here.

Citing Articles

Herb-induced Liver Injury-A Guide to Approach. Lessons from the (Giloy) Case Series Story.

Nagral A, Rudra O, Menezes S, Menon S, Shailajan S, Mallakmir S J Clin Exp Hepatol. 2023; 13(2):360-371.

PMID: 36950495 PMC: 10025683. DOI: 10.1016/j.jceh.2022.11.001.

Hepatotoxicity due to herbal dietary supplements: Past, present and the future.

Gurley B, McGill M, Koturbash I Food Chem Toxicol. 2022; 169:113445.

PMID: 36183923 PMC: 11404749. DOI: 10.1016/j.fct.2022.113445.

On Speeding Up and The Lunar Mare.

Premkumar M, Anand A J Clin Exp Hepatol. 2022; 12(1):10-12.

PMID: 35068779 PMC: 8766701. DOI: 10.1016/j.jceh.2021.11.015.

References

Guzman G, Kallwitz E, Wojewoda C, Chennuri R, Berkes J, Layden T . Liver Injury with Features Mimicking Autoimmune Hepatitis following the Use of Black Cohosh. Case Rep Med. 2010; 2009:918156. PMC: 2814377. DOI: 10.1155/2009/918156. View

Nagral A, Adhyaru K, Rudra O, Gharat A, Bhandare S . Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series. J Clin Exp Hepatol. 2021; 11(6):732-738. PMC: 8252698. DOI: 10.1016/j.jceh.2021.06.021. View

Lammert C, Zhu C, Lian Y, Raman I, Eckert G, Li Q . Exploratory Study of Autoantibody Profiling in Drug-Induced Liver Injury with an Autoimmune Phenotype. Hepatol Commun. 2020; 4(11):1651-1663. PMC: 7603536. DOI: 10.1002/hep4.1582. View

Bjornsson E, Bergmann O, Bjornsson H, Kvaran R, Olafsson S . Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013; 144(7):1419-25, 1425.e1-3. DOI: 10.1053/j.gastro.2013.02.006. View

Chalasani N, Bonkovsky H, Fontana R, Lee W, Stolz A, Talwalkar J . Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study. Gastroenterology. 2015; 148(7):1340-52.e7. PMC: 4446235. DOI: 10.1053/j.gastro.2015.03.006. View

Ravi S, Shoreibah M, Raff E, Bloomer J, Kakati D, Rasheed K . Autoimmune Markers Do Not Impact Clinical Presentation or Natural History of Steatohepatitis-Related Liver Disease. Dig Dis Sci. 2015; 60(12):3788-93. PMC: 4637235. DOI: 10.1007/s10620-015-3795-5. View

de Boer Y, Kosinski A, Urban T, Zhao Z, Long N, Chalasani N . Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury. Clin Gastroenterol Hepatol. 2016; 15(1):103-112.e2. PMC: 5370577. DOI: 10.1016/j.cgh.2016.05.043. View

Devarbhavi H, Joseph T, Sunil Kumar N, Rathi C, Thomas V, Singh S . The Indian Network of Drug-Induced Liver Injury: Etiology, Clinical Features, Outcome and Prognostic Markers in 1288 Patients. J Clin Exp Hepatol. 2021; 11(3):288-298. PMC: 8103312. DOI: 10.1016/j.jceh.2020.11.002. View

Andrade R, Lucena M, Fernandez M, Pelaez G, Pachkoria K, Garcia-Ruiz E . Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology. 2005; 129(2):512-21. DOI: 10.1016/j.gastro.2005.05.006. View

10.

Riyaz S, Imran M, Gleeson D, Karajeh M . Khat (Catha Edulis) as a possible cause of autoimmune hepatitis. World J Hepatol. 2014; 6(3):150-4. PMC: 3959116. DOI: 10.4254/wjh.v6.i3.150. View

11.

Wei Y, Liu M, Liu J, Li H . Influence Factors on the Hepatotoxicity of . Evid Based Complement Alternat Med. 2019; 2019:5482896. PMC: 6778938. DOI: 10.1155/2019/5482896. View

12.

Adams L, Lindor K, Angulo P . The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver disease. Am J Gastroenterol. 2004; 99(7):1316-20. DOI: 10.1111/j.1572-0241.2004.30444.x. View

13.

Shen T, Liu Y, Shang J, Xie Q, Li J, Yan M . Incidence and Etiology of Drug-Induced Liver Injury in Mainland China. Gastroenterology. 2019; 156(8):2230-2241.e11. DOI: 10.1053/j.gastro.2019.02.002. View

14.

Teka T, Wang L, Gao J, Mou J, Pan G, Yu H . Polygonum multiflorum: Recent updates on newly isolated compounds, potential hepatotoxic compounds and their mechanisms. J Ethnopharmacol. 2021; 271:113864. DOI: 10.1016/j.jep.2021.113864. View

15.

Suk K, Kim D, Kim C, Park S, Yoon J, Kim Y . A prospective nationwide study of drug-induced liver injury in Korea. Am J Gastroenterol. 2012; 107(9):1380-7. DOI: 10.1038/ajg.2012.138. View

16.

Vega M, Verma M, Beswick D, Bey S, Hossack J, Merriman N . The Incidence of Drug- and Herbal and Dietary Supplement-Induced Liver Injury: Preliminary Findings from Gastroenterologist-Based Surveillance in the Population of the State of Delaware. Drug Saf. 2017; 40(9):783-787. PMC: 5699929. DOI: 10.1007/s40264-017-0547-9. View

17.

Bjornsson E, Talwalkar J, Treeprasertsuk S, Kamath P, Takahashi N, Sanderson S . Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology. 2010; 51(6):2040-8. DOI: 10.1002/hep.23588. View

18.

Bjornsson H, Gudbjornsson B, Bjornsson E . Infliximab-induced liver injury: Clinical phenotypes, autoimmunity and the role of corticosteroid treatment. J Hepatol. 2021; 76(1):86-92. DOI: 10.1016/j.jhep.2021.08.024. View

19.

Chalasani N, Fontana R, Bonkovsky H, Watkins P, Davern T, Serrano J . Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology. 2008; 135(6):1924-34, 1934.e1-4. PMC: 3654244. DOI: 10.1053/j.gastro.2008.09.011. View

20.

Bjornsson E, Olsson R . Outcome and prognostic markers in severe drug-induced liver disease. Hepatology. 2005; 42(2):481-9. DOI: 10.1002/hep.20800. View